This is unpublished
Full application due December 19, 2024.
Important dates
| RFA Release | August 21, 2024 |
| REQUIRED: Non-Binding Letter of Intent Form | November 10, 2024 |
| RECOMMENDED: Consultation Appointment Deadline | November 18, 2024 |
| Application Deadline | December 19, 2024 |
| Review Date | Jan - Feb 2025 |
| Earliest Award Date | March 2025 |
Types of Projects Supported
TB-related research is defined broadly and includes basic science, clinical, epidemiological, behavioral, and implementation science research.
budget
$50,000 per year for up to two years of funding. Funds can be used for both salary support and research/experimental costs. Approximately two NIAs will be given annually with a goal to fund one in basic/translational/data science and one in clinical/epidemiology/implementation science.
elgibility criteria
- MD or PhD or equivalent terminal degree (including an MBChB plus a Master’s Degree).
- New or Early Stage Investigators as defined by the NIH including:
- Post-doctoral and clinical fellows
- Early-Stage faculty (Assistant Professor and earlier)
- Individual Principal Investigators (PIs). We do not allow Co-PIs to apply
- NIH K-awardees (clear differentiation in the scope of work between the K-award and NIA)
- Our primary mission is to support Seattle-based TB researchers; all applicants must have an established, primary mentor at a Seattle-based TRAC affiliated institution
- Enroll as a SEATRAC member
- SEATRAC is committed to ensure a diverse workforce and encourages applications from individuals that are historically underrepresented defined by the NIH.
- Applicants may submit only one application to this program per cycle. We accept applicant resubmissions of prior-year NIA proposals that have been revised to address previous NIA reviewer critiques.